Clinical trial
The Effect of a Probiotic on Hepatic Steatosis
NCT00099723 · VSL Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00099723 |
|---|---|
| Title | The Effect of a Probiotic on Hepatic Steatosis |
| Official title | The Effect of a Probiotic on Hepatic Steatosis |
| Lead sponsor | VSL Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fatty Liver |
| Intervention type | Drug |
| Interventions | VSL#3 |
| Enrollment | 30 |
| Start date | Oct 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Dec 20, 2004 |
| Last update posted | Feb 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: